thrombin

Animal productexperimental

Clinical trial activity

13 trials · 14 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
4
Phase 3
2
Phase 4
3

Earliest trial started Jan 1, 2008 (NCT00544310)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2009

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • adhexil

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06664775Phase 3Nov 25, 2024Corza Medical GmbH
NCT06379724Phase 4Jul 11, 2024University of Kansas
NCT06124209Phase 4Nov 4, 2023Medical University of Warsaw
NCT05912712Phase 1Jul 1, 2023People's Liberation Army of China
NCT05385952N/AAug 4, 2022GATT Technologies BV, Radboud University, Rutgers University
NCT04660721Phase 1/Phase 2 (Phase 2)Dec 31, 2020Sealantium Medical Ltd.
NCT04065880N/AApr 1, 2020University of Basel
NCT04357483Phase 4Feb 1, 2018University of Ulsan
NCT02781766N/AAug 8, 2016University of Lyon
NCT02785757N/AJul 12, 2014University of Lyon
NCT01650298N/AJan 31, 2013Abbott, Harvard University
NCT00865488Phase 3May 1, 2009Omrix Biopharmaceuticals, Inc.
NCT00544310Phase 1/Phase 2 (Phase 2)Jan 1, 2008Omrix Biopharmaceuticals, Inc.
Showing 13 of 13 trials
Page 1 / 1

Organizations

Research & Development (14)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Omrix Biopharmaceuticals, Inc.For profit2222008
University of LyonAcademic/Hospital2212014
AbbottFor profit1112013
Corza Medical GmbHFor profit1112024
GATT Technologies BVFor profit1112022
Harvard UniversityAcademic/Hospital1012013
Medical University of WarsawAcademic/Hospital1112023
People's Liberation Army of ChinaGovernment1112023
Radboud UniversityAcademic/Hospital1012022
Rutgers UniversityAcademic/Hospital1012022
Sealantium Medical Ltd.For profit1112020
University of BaselAcademic/Hospital1112020
University of KansasAcademic/Hospital1112024
University of UlsanAcademic/Hospital1112018
14 organizations
Page 1 / 1